疫苗制造商Novavax (NVAX)股价经历了一年的过山车式波动。5月，该公司宣布与生物科技巨头赛诺菲达成一项利润丰厚的协议后，股价飙升。自那以后，Novavax的股价一直在走下坡路，不过这可能是由于一些投资者获利回吐。

Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

However, Novavax's shares recently dropped by about 20% in one day after it announced a clinical setback. The biotech's stock ...

An analysis by Li Tao, MD, MS, PhD, director of real-world evidence at Gilead Sciences, and colleagues looked at statistical ...

Asia Pacific: Operators in Asia Pacific will make up 7% of the five-year new jet deliveries. APAC is returning to typical fleet growth after several years of decline throughout the pandemic. There is ...

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Novavax, Inc. (“Novavax” or ...

Depending on when you last got vaccinated, that COVID-19 shot may no longer be a good match for the variants expected to ...

Malaria fight advances as Nigeria launches an innovative new vaccine R21, offering fresh hope in the battle against the ...

Depending on when you last got vaccinated, that COVID-19 shot may no longer be a good match for the variants expected to dominate this fall and winter.

Sep. 25, 2024 — Almost everyone knows about HIV. Fewer people know about its relative, HTLV-1. However, HTLV-1 can cause serious illnesses, including cancer. To develop ways to combat this virus ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

As the COVID virus continues to evolve, experts in respiratory diseases recommend that everyone ages 6 months and older ...